Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer

Cisplatin (CDDP)-based combination chemotherapy remains the mainstream treatment for advanced bladder cancer. However, its efficacy is often limited due to the development of resistance for which underlying mechanisms are poorly understood. Meanwhile, emerging evidence has indicated the involvement...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Kashiwagi, Eiji, Ide, Hiroki, Inoue, Satoshi, Kawahara, Takashi, Zheng, Yichun, Reis, Leonardo O., Baras, Alexander S., Miyamoto, Hiroshi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226499/
https://ncbi.nlm.nih.gov/pubmed/27322140
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9994
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia